BioNTech Phase 3 trial of variant-adapted BNT162b2 COVID vaccine recruitingSep 30Weekly roundup, 7 itemsatirmociclibberobenatide
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig, pumitamig in SCLCSep 28Trial updateBioNTech SEBoehringer Ingelheim
BioNTech posts results for mpox vaccine BNT166a Phase I/II trial NCT05988203Sep 15Trial updateBioNTech SEBNT166A
CIBINQO label updated by FDA; Pfizer's rimegepant China trial and pipeline items still activeSep 3Weekly roundup, 7 itemsabrocitinibberobenatide
BioNTech ends Phase 2 trial of autogene cevumeran in colorectal cancerAug 28Clinical readoutautogene cevumeranBioNTech SE
BioNTech posts results for Phase I/IIa malaria RNA vaccine trial; CHMI portion skippedAug 28Trial updateBioNTech SEBNT165C
FDA approves updated Pfizer-BioNTech COVID-19 vaccine targeting XFG variantAug 27Regulatory decisionBioNTech SEPfizer
FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
Genmab terminates Phase 1/2 GEN1055 trial for strategic reasons; results now postedAug 11Trial updateBioNTech SEGEN1055
BioNTech names Guido Oelkers CEO, trims 2026 revenue guidance in Q2 updateAug 4Quarterly updateBioNTech SE
Pfizer registers Phase 3 trials in alopecia areata and chronic migraine; two Phase 1 studies openJul 29Weekly roundup, 5 itemsBioNTech SEPF-08642534
Genmab-BioNTech trial of GEN1042 combos posts results after early end for lack of efficacyJul 2Trial updateBioNTech SEGEN1042
Sign in